Onconetix Inc.(ONCO)
盘后1.560.000.00%19:59 EST
1.56+0.13+9.09%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Onconetix Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Onconetix, Inc.于2018年10月26日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司，专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生（BPH）（一种前列腺疾病）的口服治疗药物EntadFi，以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原（PSA）评估不确定的男性的先进专有诊断系统Proclarix。- 2025-12-22Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend][修订]招股说明书Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 2025-12-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-12-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-04Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 2025-10-29Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-10-16Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 2025-10-03Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-09-26Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-09-22Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-09-04Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-14Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-08-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-07-16Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-16Form 8-K - Current report重要事件披露Form 8-K - Current report
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
1.70
今开
1.46
量比
3.93
最低
1.41
昨收
1.43
换手率
11.93%